Abattis Bioceuticals Corp (ATTBF)
0.00
USD |
OTCM |
May 16, 16:00
Abattis Bioceuticals Total Assets (Quarterly): 14.55M for Sept. 30, 2019
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 14.55M |
| June 30, 2019 | 15.55M |
| March 31, 2019 | 9.834M |
| December 31, 2018 | 9.655M |
| September 30, 2018 | 8.823M |
| June 30, 2018 | 52.87M |
| March 31, 2018 | 56.17M |
| December 31, 2017 | 8.981M |
| September 30, 2017 | 0.9735M |
| June 30, 2017 | 2.013M |
| March 31, 2017 | 1.411M |
| December 31, 2016 | 1.24M |
| September 30, 2016 | 0.9641M |
| June 30, 2016 | 0.998M |
| March 31, 2016 | 1.043M |
| December 31, 2015 | 1.221M |
| September 30, 2015 | 1.202M |
| June 30, 2015 | 3.778M |
| March 31, 2015 | 4.110M |
| December 31, 2014 | 4.747M |
| September 30, 2014 | 5.289M |
| June 30, 2014 | 5.277M |
| Date | Value |
|---|---|
| March 31, 2014 | 5.501M |
| December 31, 2013 | 1.502M |
| September 30, 2013 | 1.580M |
| June 30, 2013 | 1.752M |
| March 31, 2013 | 1.931M |
| December 31, 2012 | 1.880M |
| September 30, 2012 | 1.351M |
| June 30, 2012 | 0.7676M |
| March 31, 2012 | 0.8534M |
| December 31, 2011 | 0.6973M |
| September 30, 2011 | 0.692M |
| June 30, 2011 | 0.638M |
| March 31, 2011 | 0.5844M |
| December 31, 2010 | 0.7282M |
| September 30, 2010 | 0.7871M |
| June 30, 2010 | 0.6732M |
| December 31, 2009 | 0.6086M |
| September 30, 2009 | 0.7029M |
| June 30, 2009 | 0.1164M |
| March 31, 2009 | 0.0001M |
| September 30, 2008 | 0.0002M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.55M
Minimum
Sep 2019
15.55M
Maximum
Jun 2019
15.05M
Average
15.05M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.492M |
| Shareholders Equity (Quarterly) | 8.368M |